BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 33298608)

  • 1. A Short-Tandem-Repeat Assay (
    Nyuykonge B; Eadie K; Zandijk WHA; Ahmed SA; Desnos-Ollivier M; Fahal AH; de Hoog S; Verbon A; van de Sande WWJ; Klaassen CHW
    J Clin Microbiol; 2021 Feb; 59(3):. PubMed ID: 33298608
    [No Abstract]   [Full Text] [Related]  

  • 2. Madurella mycetomatis grains within a eumycetoma lesion are clonal.
    Nyuykonge B; Siddig EE; Konings M; Bakhiet S; Verbon A; Klaassen CHW; Fahal AH; van de Sande WWJ
    Med Mycol; 2022 Jul; 60(7):. PubMed ID: 35833294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. VNTR confirms the heterogeneity of Madurella mycetomatis and is a promising typing tool for this mycetoma causing agent.
    Lim W; Eadie K; Horst-Kreft D; Ahmed SA; Fahal AH; van de Sande WWJ
    Med Mycol; 2019 Jun; 57(4):434-440. PubMed ID: 30085253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Madurella mycetomatis strains from mycetoma lesions in Sudanese patients are clonal.
    Ahmed A; van de Sande W; Verbrugh H; Fahal A; van Belkum A
    J Clin Microbiol; 2003 Oct; 41(10):4537-41. PubMed ID: 14532179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic implications of mycetoma derived from Madurella pseudomycetomatis isolates from Mexico.
    Nyuykonge B; Klaassen CHW; Zandijk WHA; de Hoog GS; Ahmed SA; Desnos-Ollivier M; Verbon A; Bonifaz A; van de Sande WWJ
    J Eur Acad Dermatol Venereol; 2020 Aug; 34(8):1828-1834. PubMed ID: 32233084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomics and metagenomics of Madurella mycetomatis, a causative agent of black grain mycetoma in Sudan.
    Litvintseva AP; Bakhiet S; Gade L; Wagner DD; Bagal UR; Batra D; Norris E; Rishishwar L; Beer KD; Siddig EE; Mhmoud NA; Chow NA; Fahal A
    PLoS Negl Trop Dis; 2022 Nov; 16(11):e0010787. PubMed ID: 36322569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The development of a novel diagnostic PCR for Madurella mycetomatis using a comparative genome approach.
    Lim W; Siddig E; Eadie K; Nyuykonge B; Ahmed S; Fahal A; Verbon A; Smit S; van de Sande WW
    PLoS Negl Trop Dis; 2020 Dec; 14(12):e0008897. PubMed ID: 33326425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiological cut-off values for itraconazole and ravuconazole for Madurella mycetomatis, the most common causative agent of mycetoma.
    Nyuykonge B; Siddig EE; Mhmoud NA; Nyaoke BA; Zijlstra EE; Verbon A; Bakhiet S; Fahal AH; van de Sande WWJ
    Mycoses; 2022 Dec; 65(12):1170-1178. PubMed ID: 36005544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a species-specific PCR-restriction fragment length polymorphism analysis procedure for identification of Madurella mycetomatis.
    Ahmed AO; Mukhtar MM; Kools-Sijmons M; Fahal AH; de Hoog S; van den Ende BG; Zijlstra EE; Verbrugh H; Abugroun ES; Elhassan AM; van Belkum A
    J Clin Microbiol; 1999 Oct; 37(10):3175-8. PubMed ID: 10488173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Polymorphism in the Chitotriosidase Gene Associated with Risk of Mycetoma Due to Madurella mycetomatis Mycetoma--A Retrospective Study.
    Verwer PE; Notenboom CC; Eadie K; Fahal AH; Verbrugh HA; van de Sande WW
    PLoS Negl Trop Dis; 2015; 9(9):e0004061. PubMed ID: 26332238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential utility of random amplified polymorphic DNA (RAPD) and restriction endonuclease assay (REA) as typing systems for Madurella mycetomatis.
    Lopes MM; Freitas G; Boiron P
    Curr Microbiol; 2000 Jan; 40(1):1-5. PubMed ID: 10568795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple extensive Madurella mycetomatis eumycetoma lesions: a case report and review of the literature.
    Zaid DM; Bakheet OE; Ahmed ES; Abdalati F; Mhmoud NA; Mohamed ESW; Bakhiet SM; Siddig EE; Fahal AH
    Trans R Soc Trop Med Hyg; 2021 Apr; 115(4):411-414. PubMed ID: 33406268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mycetoma caused by Madurella mycetomatis: a neglected infectious burden.
    Ahmed AO; van Leeuwen W; Fahal A; van de Sande W; Verbrugh H; van Belkum A
    Lancet Infect Dis; 2004 Sep; 4(9):566-74. PubMed ID: 15336224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The synthetic synergistic cinnamon oil CIN-102 is active against Madurella mycetomatis, the most common causative agent of mycetoma.
    Konings M; Eadie K; Lim W; Fahal AH; Mouton J; Tesse N; van de Sande WWJ
    PLoS Negl Trop Dis; 2021 Jun; 15(6):e0009488. PubMed ID: 34106933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metagenomic detection of eumycetoma causative agents   from households of patients residing in two Sudanese endemic villages in White Nile State.
    Santona A; Mhmoud NA; Siddig EE; Deligios M; Fiamma M; Paglietti B; Bakhiet SM; Rubino S; Fahal AH
    PLoS Negl Trop Dis; 2022 Aug; 16(8):e0010385. PubMed ID: 36040926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genotyping of Madurella mycetomatis by selective amplification of restriction fragments (amplified fragment length polymorphism) and subtype correlation with geographical origin and lesion size.
    van de Sande WW; Gorkink R; Simons G; Ott A; Ahmed AO; Verbrugh H; van Belkum A
    J Clin Microbiol; 2005 Sep; 43(9):4349-56. PubMed ID: 16145076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibiting DHN- and DOPA-melanin biosynthesis pathway increased the therapeutic value of itraconazole in Madurella mycetomatis infected Galleria mellonella.
    Lim W; Konings M; Parel F; Eadie K; Strepis N; Fahal A; Verbon A; van de Sande WWJ
    Med Mycol; 2022 Feb; 60(2):. PubMed ID: 35064672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phylogeny and typification of Madurella mycetomatis, with a comparison of other agents of eumycetoma.
    de Hoog GS; Adelmann D; Ahmed AO; van Belkum A
    Mycoses; 2004 Apr; 47(3-4):121-30. PubMed ID: 15078428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Active matrix metalloprotease-9 is associated with the collagen capsule surrounding the Madurella mycetomatis grain in mycetoma.
    Geneugelijk K; Kloezen W; Fahal AH; van de Sande WW
    PLoS Negl Trop Dis; 2014 Mar; 8(3):e2754. PubMed ID: 24675764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fructose-bisphosphate aldolase and pyruvate kinase, two novel immunogens in Madurella mycetomatis.
    de Klerk N; de Vogel C; Fahal A; van Belkum A; van de Sande WW
    Med Mycol; 2012 Feb; 50(2):143-51. PubMed ID: 21728753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.